Dr. Ilhan sabancilar is a biomedical researcher focusing on cell culture studies, cytotoxicity, antioxidant mechanisms, and vitamin biology. His/her research investigates the effects of natural extracts, vitamins, and bioactive compounds on cancer and normal cell lines using various in vitro models. Through the use of cell viability and cytotoxicity assays, including MTT and IC₅₀ analyses, Dr. sabancilar evaluates the therapeutic potential and safety profiles of different compounds. A significant part of his/her work also explores how antioxidants and vitamins contribute to maintaining cellular homeostasis, preventing oxidative stress, and enhancing cell survival under toxic conditions. Dr. sabancilar integrates biochemical assays (such as DPPH, FRAP and CUPRAC) with cell-based experiments to better understand the relationship between antioxidant activity and cellular response. His/her interdisciplinary approach combines principles of molecular biology, pharmacology, and biochemistry, aiming to contribute to the discovery of novel natural compounds with potential therapeutic applications.